Dokumentasjon

Share on Facebook0Tweet about this on TwitterShare on Google+0Email this to someone

Studier gjort på Recrea Forte

http://www.ncbi.nlm.nih.gov/pubmed/17902730
Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
2007 – Shin HS, Won CH, Lee SH, Kwon OS, Kim KH, Eun HC.
Department of Dermatology, Seoul National University College of Medicine, and Seoul National University Boramae Hospital, Seoul, Korea.

http://www.ncbi.nlm.nih.gov/pubmed/17917938
Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice?
2007 – Mapar MA, Omidian M.
Department of Dermatology, Imam Khomeini Hospital, Jundishapour Medical University, Ahvaz, Iran. mapar_m@yahoo.com

http://www.ncbi.nlm.nih.gov/pubmed/17202653
The additive effects of minoxidil and retinol on human hair growth in vitro.
2007 – Yoo HG, Chang IY, Pyo HK, Kang YJ, Lee SH, Kwon OS, Cho KH, Eun HC, Kim KH.
Department of Dermatology, Seoul National University College of Medicine, Korea.

http://www.ncbi.nlm.nih.gov/pubmed/15316165
An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
2004 – Arca E, Açikgöz G, Ta?tan HB, Köse O, Kurumlu Z.
Department of Dermatology, Gülhane Military Medical Academy, School of Medicine, Etlik-Ankara, Turkey. earca@gata.edu.tr

http://www.ncbi.nlm.nih.gov/pubmed/12196747
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
2002 – Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ.
Duke Dermatopharmacology Study Center, Durham, North Carolina, USA.

http://www.ncbi.nlm.nih.gov/pubmed/11886528
Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil.
2001 – Li M, Marubayashi A, Nakaya Y, Fukui K, Arase S.
Department of Dermatology, School of Medicine, The University of Tokushima, Tokushima, Japan.

http://www.ncbi.nlm.nih.gov/pubmed/9306265
Evidence for alpha 2-adrenoceptor agonist activity of minoxidil.
1997 – Sharma N, Mehta AA, Santani DD, Goyal RK.
Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, India.

http://www.ncbi.nlm.nih.gov/pubmed/2230218
Minoxidil sulfate is the active metabolite that stimulates hair follicles.
1990 – Buhl AE, Waldon DJ, Baker CA, Johnson GA.
Upjohn Company, Kalamazoo, Michigan 49001.

http://www.ncbi.nlm.nih.gov/pubmed/3314717
Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
1987 – Koperski JA, Orenberg EK, Wilkinson DI.
Department of Dermatology, Stanford University School of Medicine, Calif.

http://www.ncbi.nlm.nih.gov/pubmed/3549811
Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata.
1987 – Fiedler-Weiss VC.

http://www.ncbi.nlm.nih.gov/pubmed/3549801
Dose-response study of topical minoxidil in male pattern alopecia.
1987 – Shupack JL, Kassimir JJ, Thirumoorthy T, Reed ML, Jondreau L.

http://www.ncbi.nlm.nih.gov/pubmed/3549808
Deaths occurring during clinical studies of topical minoxidil.
1987 – Spindler JR.<p><small>Kassimir JJ, Thirumoorthy T, Reed ML, Jondreau L.

http://www.ncbi.nlm.nih.gov/pubmed/3722507
Dose-response study of topical minoxidil in male pattern baldness.
1986 – Olsen EA, DeLong ER, Weiner MS.

 

Studier gjort på Propecia

Det finnes en rekke studier gjort på Propecia. Her finner du en liste over de største:

http://www.ncbi.nlm.nih.gov/pubmed/21980923
Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
2012 – Sato A, Takeda A.
Tokyo Memorial Clinic Hirayama Department of Plastic and Aesthetic Surgery, School of Medicine, Kitasato University, Tokyo, Japan. drsato@crux.ocn.ne.jp

http://www.ncbi.nlm.nih.gov/pubmed/21910805
Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.
2011 – Rossi A, Cantisani C, Scarnò M, Trucchia A, Fortuna MC, Calvieri S.
Department of Dermatology and Plastic Surgery, University «Sapienza» of Rome CASPUR (Inter-University Consortium for Supercomputing), Italy. Alfredo.rossi@uniroma1.it

http://www.ncbi.nlm.nih.gov/pubmed/21418145
Persistent sexual side effects of finasteride for male pattern hair loss.
2011 – Irwig MS, Kolukula S.
Center for Andrology and Division of Endocrinology, The George Washington University, Washington, DC 20037, USA. mirwig@mfa.gwu.edu

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205531/
Finasteride and male fertility
2011 – Dilip Gude

http://www.ncbi.nlm.nih.gov/pubmed/16834758
A new look at the 5alpha-reductase inhibitor finasteride.
2006 – Finn DA, Beadles-Bohling AS, Beckley EH, Ford MM, Gililland KR, Gorin-Meyer RE, Wiren KM.
Department of Veterans Affairs Medical Research, Portland Alcohol Research Center, 97239, USA. finnd@ohsu.edu

http://www.ncbi.nlm.nih.gov/pubmed/16536818
Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
2006 – Ryu HK, Kim KM, Yoo EA, Sim WY, Chung BC.
Bioanalysis and Biotransformation Research Centre, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul, 130-605, Korea.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472914/
Comparison of Clinical Trials With Finasteride and Dutasteride
2004 – J. Curtis Nickel

http://www.ncbi.nlm.nih.gov/pubmed/9951956
Finasteride: a review of its use in male pattern hair loss.
1999 – McClellan KJ, Markham A.
Adis International Limited, Mairangi Bay, Auckland, New Zealand. demail@adis.co.nz

http://www.ncbi.nlm.nih.gov/pubmed/9777765
Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
1998 – Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ.
Department of Clinical Research, Merck Research Laboratories, Rahway, NJ 07065, USA.

Share on Facebook0Tweet about this on TwitterShare on Google+0Email this to someone

Be the first to comment

Leave a Reply

Epostadressen din vil ikke vises.


*